Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Non-Current Debt (2016 - 2026)

Option Care Health (OPCH) has disclosed Non-Current Debt for 17 consecutive years, with $1.2 billion as the latest value for Q1 2026.

  • For Q1 2026, Non-Current Debt rose 4.43% year-over-year to $1.2 billion; the TTM value through Mar 2026 reached $1.2 billion, up 4.43%, while the annual FY2025 figure was $1.2 billion, 4.47% up from the prior year.
  • Non-Current Debt hit $1.2 billion in Q1 2026 for Option Care Health, roughly flat from $1.2 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.2 billion in Q3 2025 and bottomed at $1.1 billion in Q1 2024.
  • Average Non-Current Debt over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2022.
  • Year-over-year, Non-Current Debt dropped 5.5% in 2022 and then grew 4.56% in 2024.
  • Option Care Health's Non-Current Debt stood at $1.1 billion in 2022, then fell by 0.15% to $1.1 billion in 2023, then grew by 4.54% to $1.1 billion in 2024, then rose by 4.47% to $1.2 billion in 2025, then fell by 0.09% to $1.2 billion in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $1.2 billion, $1.2 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.